• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Apoptosis-Induced T Cell Lymphopenia Is Related to COVID-19 Severity

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Dec 17.
doi: 10.1002/jmv.26742. Online ahead of print.
Apoptosis-Induced T Cell Lymphopenia Is Related to COVID-19 Severity


Ahmet Cizmecioglu[SUP] 1 [/SUP], Hilal Akay Cizmecioglu[SUP] 2 [/SUP], Mevlut Hakan Goktepe[SUP] 2 [/SUP], Ayca Emsen[SUP] 3 [/SUP], Celalettin Korkmaz[SUP] 4 [/SUP], Fatma Esenkaya Tasbent[SUP] 5 [/SUP], Fatma Colkesen[SUP] 6 [/SUP], Hasibe Artac[SUP] 7 [/SUP]



Affiliations

Abstract

Background: Increased levels of acute-phase reactants and lymphopenia are predictors of disease severity in Coronavirus Disease 2019 (COVID-19). This study aimed to investigate the role of apoptosis in the etiology of lymphopenia in patients with COVID-19.
Methods/setting: This multicentered, prospective, and case-control study was conducted with polymerase chain reaction (PCR) (+) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients, and an age-gender matched control group. Samples were taken at the time of diagnosis and analyzed via flow cytometry within 24 hours. The participants' demographic data and initial laboratory tests were also recorded.
Results: In total, 33 patients with COVID-19 (mean age = 45.4 ? 17.2) and 25 controls (mean age = 43.4 ? 17.4) participated in the study. All patients were identified as having mild (16), moderate (5), or severe (12) disease severity. Both early and late apoptotic cells in B and T lymphocytes were increased in all patients with COVID-19 (p < 0.05). Early apoptotic B and T lymphocytes were also higher in severe cases compared to mild cases (p = 0.026). There was no significant difference between lymphopenia and apoptosis in patients with COVID-19. However, patients with lymphopenia (n = 14) and severe COVID-19 (p = 0.013) had increased early apoptotic T lymphocytes.
Conclusions: This study's results show that B and T lymphocytes' apoptosis increases in patients with COVID-19. Additionally, enhanced T lymphocyte apoptosis is associated with disease severity in lymphopenic patients with COVID-19. This article is protected by copyright. All rights reserved.

Keywords: Apoptosis; COVID-19; Disease severity; Lymphopenia.
 
Back
Top Bottom